Jin-Ming Xiong

Statistics

Publications

Citations

229

H-Index

Active since

2009

Affiliations

Gilead Sciences (United States)(Current)

Jin-Ming Xiong is an author at Gilead Sciences (United States) specializing in tyrosine kinase inhibitors, drug discovery, and small molecule tyrosine kinase inhibitors.

Publications per year

2009–2020

Publications

Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases

Peter Blomgren, Jayaraman Chandrasekhar, Julie A. Di Paolo et al. · ACS Medicinal Chemistry Letters · 2020 · 53 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Discovery of highly potent and selective Bruton’s tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4

Scott A. Mitchell, M. Diana Danca, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine Kinase with Improved Druglike Properties

Xiaojing Wang, J A Barbosa, Peter Blomgren et al. · ACS Medicinal Chemistry Letters · 2017 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 5